Clinical Manifestations, Differential Diagnosis, And Initial Management of Psychosis in Adults

Preview:

DESCRIPTION

PSICOSIS

Citation preview

  • 21/7/2015 Clinicalmanifestations,differentialdiagnosis,andinitialmanagementofpsychosisinadults

    http://www.uptodate.com.scihub.club/contents/clinicalmanifestationsdifferentialdiagnosisandinitialmanagementofpsychosisinadults?topicKey=P 1/16

    OfficialreprintfromUpToDate www.uptodate.com.scihub.club2015UpToDate

    AuthorsStephenMarder,MDMichaelDavis,MD,PhD

    SectionEditorMurrayBStein,MD,MPH

    DeputyEditorRichardHermann,MD

    Clinicalmanifestations,differentialdiagnosis,andinitialmanagementofpsychosisinadults

    Alltopicsareupdatedasnewevidencebecomesavailableandourpeerreviewprocessiscomplete.Literaturereviewcurrentthrough:Jun2015.|Thistopiclastupdated:Sep22,2014.

    INTRODUCTIONPsychosisisaconditionofthemindbroadlydefinedasalossofcontactwithreality.Itisestimatedthat13to23percentofpeopleexperiencepsychoticsymptomsatsomepointintheirlifetime,and1to4percentwillmeetcriteriaforapsychoticdisorder[1,2].

    Psychoticsymptomscanincreasepatientsriskforharmingthemselvesorothersorbeingunabletomeettheirbasicneeds.Mostclinicianswillencounterpatientswithpsychosisandwillthusbenefitfromknowinghowtorecognizepsychoticsymptomsandmakeappropriateinitialevaluationandmanagementdecisions.Otherclinicians,particularlymentalhealthspecialists,willconductamorethoroughpatientassessment,considerthepatientsdifferentialdiagnosis,anddeterminethepatientsdiagnosistoguidelongtermtreatment.

    Thistopicwillcharacterizedifferenttypesofpsychoticsymptoms,provideguidanceforformulatingadifferentialdiagnosis,andsuggestinitialevaluationandmanagementpractices.Issuesrelatedtoantipsychoticmedications,thetreatmentofspecificdisorders,andpsychosocialinterventionsarediscussedseparately.(See"Secondgenerationantipsychoticmedications:Pharmacology,administration,andcomparativesideeffects"and"Firstgenerationantipsychoticmedications:Pharmacology,administration,andcomparativesideeffects"and"Schizophrenia:Epidemiologyandpathogenesis"and"Schizophrenia:Clinicalmanifestations,course,assessment,anddiagnosis"and"Pharmacotherapyforschizophrenia:Longactinginjectableantipsychoticdrugs"and"Pharmacotherapyforschizophrenia:Acuteandmaintenancephasetreatment"and"Treatmentofcooccurringschizophreniaandsubstanceusedisorder"and"Treatmentresistantschizophrenia"and"Anxietyinschizophrenia"and"Depressioninschizophrenia"and"Pharmacotherapyforschizophrenia:Sideeffectmanagement"and"Briefpsychoticdisorder"and"Psychosocialinterventionsforschizophrenia".)

    CLINICALMANIFESTATIONSPsychosiscanpresentwithawidevarietyofsignsandsymptoms[3],whicharedescribedbelow.

    DelusionsDelusionsaredefinedasstronglyheldfalsebeliefsthatarenottypicalofthepatientsculturalorreligiousbackground.Theycanbecategorizedasbizarreornonbizarrebasedontheirplausibility(eg,abeliefthatfamilymembershavebeenreplacedbybodydoublesisbizarreandabeliefthataspouseishavinganaffairisnonbizarre).Frequentlyencounteredtypesofdelusionsinclude:

    HallucinationsHallucinationscanbedefinedaswakefulsensoryexperiencesofcontentthatisnotactuallypresent.Theyaredifferentiatedfromillusions,whicharedistortionsormisinterpretationsofrealsensorystimuli.Whilehallucinationscanoccurinanyofthefivesensorymodalities,auditoryhallucinations(eg,hearingvoices)arethemostcommon,followedbyvisual,tactile,olfactory,andgustatoryhallucinations.Auditoryhallucinationscanpresentasspeech(includingspokencommandsorarunningcommentaryonthepatientsactions)orothersounds.Visualhallucinationscanrangefromrecognizableobjectstomoreunformedlightsorshadows.Olfactoryhallucinationsarefrequentlyofunpleasantodors.

    Persecutorydelusions(eg,believingoneisbeingfollowedandharassedbygangs)Grandiosedelusions(eg,believingoneisabillionaireCEOwhoownscasinosaroundtheworld)Erotomanicdelusions(eg,believingafamousmoviestarisinlovewiththem)Somaticdelusions(eg,believingonessinuseshavebeeninfestedbyworms)Delusionsofreference(eg,believingdialogueonatelevisionprogramisdirectedspecificallytowardsthepatient)

    Delusionsofcontrol(eg,believingonesthoughtsandmovementsarecontrolledbyplanetaryoverlords)

    SciHub.

  • 21/7/2015 Clinicalmanifestations,differentialdiagnosis,andinitialmanagementofpsychosisinadults

    http://www.uptodate.com.scihub.club/contents/clinicalmanifestationsdifferentialdiagnosisandinitialmanagementofpsychosisinadults?topicKey=P 2/16

    ThoughtdisorganizationEvidenceforthoughtdisorganizationisderivedfrompatientspatternsofspeechduringtheinterview.Whiledisorganizedspeechisafrequentlyobservedsymptominpsychosis,itisnonspecificandcanalsobepresentindeliriumorotherneurologicalorcognitivedisorders.Commonlyobservedformsofthoughtdisorganizationinclude:

    Agitation/aggressionAgitationisanacutestateofanxiety,heightenedemotionalarousal,andincreasedmotoractivity.Althoughnotspecifictopsychosis,untreatedpsychosisisassociatedwithanincreasedriskforagitationandaggressivebehaviors.Thesecansometimesleadtointentionalorunintentionalbodilyharmtoselforothers.Cliniciansshouldobservethepatientsbehaviors,includingbodylanguageandvoiceintonation,anduseappropriatesafetymeasuresfortheevaluation.(See"Assessmentandemergencymanagementoftheacutelyagitatedorviolentadult".)

    DIFFERENTIALDIAGNOSISPsychoticsymptomscanbeassociatedwithawidevarietyofprimarypsychiatricandmedicalillnesses.Clinicalfeaturesofthepsychosisarenotpathognomonicforparticulardiagnoses,butcanprovideevidencesuggestiveofprimarypsychiatricversusmedicaletiologies.

    Eachcaseshouldbeevaluatedthoroughlypossiblecausesforpsychosisshouldnotberuledoutbythesefeaturesalone.Athoroughhistory,physicalexamination,mentalstatusexamination,andadditionaltestsasindicatedcanhelpnarrowthedifferential,ruleoutpsychoseswithtreatableunderlyingcauses,andguidetheappropriateinterventionorreferral[4].

    PrimarypsychiatricillnessesPsychiatricillnessesaregenerallyclassifiedbydiagnosticcriteriaestablishedbytheDSM5[5]ortheInternationalClassificationofDiseases(ICD,WorldHealthOrganization).Theseconstructsandcriteriaareperiodicallyrevisedbasedonresearchfindingsandexpertconsensus.

    Alogia/povertyofcontentVerylittleinformationconveyedbyspeechThoughtblockingSuddenlylosingtrainofthought,exhibitedbyabruptinterruptioninspeechLooseningofassociationSpeechcontentnotableforideaspresentedinsequencethatarenotcloselyrelated

    TangentialityAnswerstointerviewquestionsdivergingincreasinglyfromtopicbeingaskedabout(calledcircumstantialityifcontenteventuallyreturnstooriginaltopic)

    ClangingorclangassociationUsingwordsinasentencethatarelinkedbyrhymingorphoneticsimilarity(eg,Ifelldownthewellsellbell.)

    WordsaladRealwordsarelinkedtogetherincoherently,yieldingnonsensicalcontentPerseverationRepeatingwordsorideaspersistently,oftenevenafterinterviewtopichaschanged

    Associatedwithprimarypsychiatric(psychotic)disorders:

    FamilyhistoryoftenpresentInsidiousonsetOnsetinteenstomidthirtiesVariablepresentationAuditoryhallucinations

    Associatedwithprimarymedicalcondition:

    FamilyhistoryvariablypresentAcuteonsetOnsetinfortiesorolderPresentsingeneralmedicalorintensivecaresettingsNonauditoryhallucinations(eg,visual,tactile,olfactory)

    SchizophreniaThisdisorderisdefinedbythepresenceofpsychoticsymptoms(eg,delusions,hallucinations,disorganizedspeech,grosslydisorganizedorcatatonicbehavior,ordiminishedemotionalexpressionorvolition)forasignificantportionoftimeduringaonemonthperiod(orlessifsuccessfullytreated).DSM5requiresthatthesymptomsbeassociatedwithadeclineinfunctioningorfailuretoachievetheexpectedleveloffunctioning.Signsofthedisturbancemustpersistforatleastsixmonths.

  • 21/7/2015 Clinicalmanifestations,differentialdiagnosis,andinitialmanagementofpsychosisinadults

    http://www.uptodate.com.scihub.club/contents/clinicalmanifestationsdifferentialdiagnosisandinitialmanagementofpsychosisinadults?topicKey=P 3/16

    Schizoaffectivedisorder,mooddisorderswithpsychoticfeatures,andattributiontosubstanceuseormedicalconditionsmustberuledout.Additionaldiagnosticrequirementsmustbemetifthereisahistoryofanotherchildhoodonsetpsychiatricdisorder.(See"Schizophrenia:Clinicalmanifestations,course,assessment,anddiagnosis".)

    SchizophreniformdisorderThisdisordercanbeconsideredtohavesimilarsymptomaticpresentationasschizophrenia,exceptwithanepisodelastinggreaterthanonemonthbutlessthansixmonths.Inaddition,functionaldeclinedoesnotneedtobepresent.Schizoaffectivedisorder,mooddisorderswithpsychoticfeatures,andattributiontosubstanceuseormedicalcondition(s)mustberuledout.

    SchizoaffectivedisorderThisdisorderisdefinedbytheindividualhavinganuninterruptedperiodofillnessduringwhichthereisamajormoodepisodeconcurrentwithpsychoticsymptomsaswellasdelusionsorhallucinationsfortwoormoreweeksintheabsenceofamajormoodepisodeduringthedurationoftheillness.Individualswiththisdisordermusthavesymptomsthatmeetcriteriaforamajormooddisorderforthemajorityofthetotaldurationoftheactiveandresidualportionsoftheillness.Disorderpresentationcannotbeattributabletosubstanceuseoranothermedicalcondition.

    DelusionaldisorderThisdisorderischaracterizedbythepresenceofone(ormore)delusionswithadurationofonemonthorlongertheabsenceofmeetingcriteriaforschizophreniaalackofmarkedimpairmentinfunctioningorobviousbizarrebehaviorsandalackofattributiontomanicordepressiveepisodes,substances,othermedicalconditions,orbetterexplanationbyanothermentaldisorder.Thedelusionsareclassifiedaserotomanictype,grandiosetype,jealoustype,persecutorytype,somatictype,mixedtype,orunspecifiedtype,andbywhethertheyhavebizarrecontent.(See"Delusionalparasitosis:Epidemiology,clinicalpresentation,assessmentanddiagnosis"and"Treatmentofdelusionalparasitosis".)

    BriefpsychoticdisorderThisdisorderischaracterizedbythepresenceofpsychoticsymptoms(eg,delusions,hallucinations,disorganizedspeech,orgrosslydisorganizedorcatatonicbehavior)withdurationonedayand

  • 21/7/2015 Clinicalmanifestations,differentialdiagnosis,andinitialmanagementofpsychosisinadults

    http://www.uptodate.com.scihub.club/contents/clinicalmanifestationsdifferentialdiagnosisandinitialmanagementofpsychosisinadults?topicKey=P 4/16

    SubstanceinducedpsychosesManyprescriptionmedicationsaswellasillicitsubstancescaninducetransientpsychoticsymptoms[6].TheDSM5definessubstance/medicationinducedpsychoticdisorderashavingthepresenceofdelusionsand/orhallucinationsduringorsoonafterintoxication,withdrawal,orexposuretoasubstance,withthedisturbancenotbeingbetterexplainedbyanothertypeofpsychoticdisorder.Thedisturbancecannotoccurexclusivelyduringthecourseofadeliriumandmustcausesignificantdistressorimpairmentinfunction.Atablelistsmajorsubstances,medications,andtoxinsthatcancausetransientpsychoses(table1).

    PsychosesassociatedwithmedicalorneurologicalconditionsAlargenumberofmedicalillnessescanbeaccompaniedbypsychoticsymptoms.Presentinganddistinguishingcharacteristicsofthesediseasesaredescribedseparately.

    DeliriumAdeliriumisanacutementaldisturbancecharacterizedbyproblemsofattention,confusion,anddisorientation.Itoftenpresentssuddenlyandfluctuatesinintensity.Deliriumfrequentlyisassociatedwithpsychoticsymptoms[7]andcanimprovefollowingantipsychotictreatment[8].Frequentcausesofdeliriumincludefluidorelectrolyteabnormalities,hypoglycemia,hypoxia,hypercapnea,infections,ormedications,substanceintoxicationorwithdrawalaredescribedinatable(table1).(See"Diagnosisofdeliriumandconfusionalstates".)

    DIAGNOSTICEVALUATIONPrimarypsychiatricillnessesaregenerallydiagnosesofexclusion.Itisimportanttoconductathoroughevaluationofpsychoticsymptoms,particularlyoninitialpresentation[10],inordertoidentifytreatableunderlyingcauses.

    InterviewTheinterviewshouldfocusonestablishingatimelineofsymptoms,apsychiatrichistoryincluding

    mustbesevereenoughtocausemarkedimpairmentinsocialoroccupationalfunctioningortonecessitatehospitalizationtopreventharmtoselforothers,ortherearepsychoticfeatures.Theepisodesalsocannotbeattributabletosubstanceuseorothermedicalconditions.(See"Bipolardisorderinadults:Clinicalfeatures",sectionon'Psychosis'.)

    EndocrinedisordersThyroiddisease,parathyroiddisease,adrenaldisease.(See"Diagnosisofhyperthyroidism"and"Primaryhyperparathyroidism:Clinicalmanifestations"and"Diagnosisofadrenalinsufficiencyinadults".)

    HepaticandrenaldisordersHepaticencephalopathy,uremicencephalopathy.(See"Hepaticencephalopathyinadults:Clinicalmanifestationsanddiagnosis".)

    InfectiousdiseaseHIV,syphilis,herpessimplexencephalitis,Lymedisease,priondisorders.(See"AcuteandearlyHIVinfection:Clinicalmanifestationsanddiagnosis"and"Pathogenesis,clinicalmanifestations,andtreatmentofearlysyphilis"and"Epidemiology,clinicalmanifestations,anddiagnosisofgenitalherpessimplexvirusinfection"and"DiagnosisofLymedisease"and"Diseasesofthecentralnervoussystemcausedbyprions".)

    InflammatoryordemyelinatingdisordersAntiNMDAreceptorencephalitis,systemiclupuserythematosus,multiplesclerosis,leukodystrophies.(See"Paraneoplasticandautoimmuneencephalitis"and"Diagnosisofmultiplesclerosisinadults"and"Diagnosisanddifferentialdiagnosisofsystemiclupuserythematosusinadults"and"Differentialdiagnosisofacutecentralnervoussystemdemyelinationinchildren".)

    MetabolicdisordersoracuteprocessesWilsonsdisease,acuteintermittentporphyria.(See"Wilsondisease:Clinicalmanifestations,diagnosis,andnaturalhistory"and"Porphyrias:Anoverview".)

    Neurodegenerativedisorders[9]Alzheimersdisease,dementiawithLewybodies,Parkinsonsdisease,Huntingtonsdisease.(See"Evaluationofcognitiveimpairmentanddementia".)

    NeurologicalHeadtrauma/traumaticbraininjury,spaceoccupyinglesions(tumors,cysts),seizuredisordersstroke.(See"Clinicalpresentationanddiagnosisofbraintumors".)

    VitamindeficiencyVitaminB12deficiency.(See"DiagnosisandtreatmentofvitaminB12andfolatedeficiency".)

  • 21/7/2015 Clinicalmanifestations,differentialdiagnosis,andinitialmanagementofpsychosisinadults

    http://www.uptodate.com.scihub.club/contents/clinicalmanifestationsdifferentialdiagnosisandinitialmanagementofpsychosisinadults?topicKey=P 5/16

    priordiagnosesandtreatments,asubstanceusehistory,afamilyhistoryforpsychiatricillness,andacompletemedicalhistory.Disorganizedthinkingmaypreventthepatientfromgivingacoherenthistory.Additionally,patientsmaynotspontaneouslyreportpsychoticsymptomsanypatientinwhompsychoticsymptomsaresuspectedshouldbeaskeddirectlyaboutexperiencinghallucinations,suspiciousness,thoughtreading,specialmessagesfromTVorradio,andspecialpowersorabilities.Theclinicianshouldseekcorroborativesourcesofinformation,wheneverpossible,forevidenceofdelusionalorreferentialthinkingorotherunusualbehaviors.

    MentalstatusexaminationAcompletementalstatusexaminationshouldbeconducted,payingparticularattentiontothepatientsappearance(grooming,hygiene)andgeneralbehaviors,moodandaffect,thoughtprocesses,evidenceforperceptualdisturbances(respondingtointernalstimuli),unusualthoughtcontent,attention,andmemoryfunction.

    Commonmedicalworkup

    Additionalteststoconsiderbasedonotherevidence

    DifferentiationbetweenDSM5psychoticdisordersIfsubstances,medications,orunderlyingmedicalconditionshavebeenruledoutascausesforpsychoticsymptoms,aprimarypsychiatricdisordershouldbeconsidered.Whendeterminingthespecificdisorder,theassociatedsymptomsandtimecoursearetheprimarydifferentiators[11].

    Ifclinicallysignificantmoodsymptomsarepresent(depressiveormanicsymptoms),thenmajordepressivedisorderwithpsychoticfeatures,bipolardisorderwithpsychoticfeatures,orschizoaffectivedisordershouldbeconsideredaspossibilities.Iftheindividualhasneverhadpsychoticsymptomswithoutmoodsymptoms,thediagnosiswillbemajordepressivedisorderwithpsychoticfeaturesorbipolardisorderwithpsychoticfeatures(dependingonahistoryofmanicsymptoms).Iftheindividualhasanoverlapofmoodsymptomswithpsychosisforthemajority(butnotall)ofthepsychoticillness,schizoaffectivedisorderwillbethelikelydiagnosis.

    Ifthereisamorelimitedoverlapofpsychosisandmoodsymptoms(eithernooverlaporoverlaponlyforaminorityoftheillnessduration),thenbriefpsychoticdisorder,schizophreniformdisorder,schizophrenia,ordelusionaldisorderwouldbepossiblediagnoses.Thedurationofthepsychoticepisodewilldifferentiatebetweenbriefpsychoticdisorder(sixmonths).

    Delusionaldisorderwouldbeconsideredifthepsychoticsymptomsarelimitedtodelusions,functioningisnotmarkedlyimpaired,andothersymptomsandbehaviorsassociatedwithschizophreniaarenotpresent.Schizotypalpersonalitydisorderwouldbeconsideredifthereisnoperiodofsignificantpersistentpsychotic

    ChemistrypaneltoevaluatefordisturbancesinfluidorelectrolytesCompletebloodcounttoevaluateforinfectiousprocessesbloodcultureifindicatedHepaticfunctionpaneltoevaluateforliverabnormalitiesThyroidstimulatinghormoneleveltoruleoutthyroiddiseaseVDRL/RPRtoscreenforsyphilisUrinalysistoevaluateforurinarytractinfectionorotherabnormalitiesurinecultureifindicatedUrinedrugscreentoevaluateforrecentsubstanceuseVitaminB12levelstoevaluatefordeficiencyHIVtoevaluateforinfection

    Computedtomography(CT)brainormagneticresonanceimaging(MRI)toevaluateforspaceoccupyinglesions,demyelinatingdisorders,orstroke

    Electroencephalogram(EEG)LumbarpunctureHeavymetalscreenRheumatologicworkup(eg,antinuclearantibody,antiribosomeantibody,antiNMDAreceptorantibody)Hormonelevels

  • 21/7/2015 Clinicalmanifestations,differentialdiagnosis,andinitialmanagementofpsychosisinadults

    http://www.uptodate.com.scihub.club/contents/clinicalmanifestationsdifferentialdiagnosisandinitialmanagementofpsychosisinadults?topicKey=P 6/16

    symptomsandifthereisapervasivepatternofsocialandinterpersonaldeficitsmarkedbyacutediscomfortwith,andreducedcapacityfor,closerelationshipsaswellasbycognitiveorperceptualdistortionsandeccentricitiesofbehavior[11].

    INITIALMANAGEMENTPatientswithpsychosisshouldbeevaluatedforagitation,riskofharmtothemselvesorothers,andtheirabilitytotakecareofthemselves.Patientsatriskofharmtothemselvesorothersmayneedtobehospitalized.Managementofagitatedpatientswithpsychosisisdescribedindetailseparately.Arapidlyactingfirstgenerationantipsychoticand/orarapidlyactingbenzodiazepinearesuggestedtosedateseverelyagitated,potentiallyviolentpatientswithpsychosis.(See"Assessmentandemergencymanagementoftheacutelyagitatedorviolentadult".)

    Patientswithpsychosisandtheirfamiliesshouldbeeducatedabouttheirillnesses,risksassociatedwithpsychosis(eg,increasedriskofharmtothemselvesorothers),andrisksandsideeffectsassociatedwithantipsychoticmedications.Familiesorcaregiversshouldbeadvisedtoreduceenvironmentalstimulation,notarguewithdelusionalideas,andinteractwithpsychoticpatientsinacalmandgentlemanner.

    Werecommendsymptomatictreatmentofpsychosiswithanantipsychoticmedication,evenifthepsychiatricdisorderormedicalconditionunderlyingthepsychosishasnotyetbeenestablished.Whileantipsychoticshavebeenmostextensivelystudiedinthetreatmentofschizophrenia,themedicationsappeartobebroadlyeffectiveforpsychoticsymptoms.Asexamples,metaanalyseshavefoundantipsychoticsareeffectiveinthetreatmentofpsychoticmaniainbipolardisorder[12],majordepressivedisorderwithpsychoticfeatures(whencombinedwithanantidepressant)[13],delirium[14],psychosisinParkinsonsdisease(clozapine)[15],andpsychosisofAlzheimersdisease[16].Thereislessofanevidencebasefortheiruseforrarergeneralmedicalconditions.Theuseandeffectivenessofantipsychoticdrugsforindividualdisordersanddiseasesarediscussedseparately.(See"Pharmacotherapyforschizophrenia:Acuteandmaintenancephasetreatment"and"Treatmentresistantschizophrenia"and"Briefpsychoticdisorder"and"Managementofneuropsychiatricsymptomsofdementia"and"Treatmentofdelusionalparasitosis"and"Treatmentofpostpartumpsychosis"and"Unipolarmajordepressionwithpsychoticfeatures:Acutetreatment"and"Guidelinesforprescribingclozapineinschizophrenia".)

    Ifthepsychosisisassociatedwithamooddisorderexacerbation,theunderlyingmooddisordershouldbetreatedaswell.Ifthepsychosisisassociatedwithageneralmedicalcondition,antipsychotictherapyshouldbeaddedtotheappropriatetreatmentfortheunderlyingcondition.(See"Unipolarmajordepressionwithpsychoticfeatures:Acutetreatment"and"Bipolardisorderinadults:Pharmacotherapyforacutemaniaandhypomania".)

    Antipsychoticdrugsaremosteffectiveatimprovingpositivepsychoticsymptoms(eg,hallucinations,delusions)whileofferinglessbenefitfornegativesymptoms(eg,bluntedaffect,avolition)orcognitivedeficitsthatarefrequentlyassociatedwithpsychosis.Antipsychoticscanreduceagitation[17]andmayreducesuiciderisk[18].Thebenefitsofantipsychoticsshould,however,beweighedagainsttheirrisksandpossiblesideeffects(table2).Appropriatestepsshouldbetakentomitigaterisk(eg,performingbaselineEKGsonolderadultpatientsorthosewithcardiachistoryandconsideringpossibilityforantipsychoticinducedQTcprolongation).(See"Pharmacotherapyforschizophrenia:Acuteandmaintenancephasetreatment",sectionon'Antipsychoticdrugefficacyandselection'.)

    Withtheexceptionofclozapine,whichisusedfortreatmentresistantchronicpsychosis,thereisanabsenceofrigorousevidencethatanyoneantipsychoticdrugismoreeffectivethanotherantipsychotics.Thechoiceamongantipsychoticsisusuallymadeonthebasisofsideeffectprofile,cost,andformulationsavailable(table2).

    Thedoseofmostantipsychoticdrugsshouldbetitratedfromaninitialdosetothetherapeuticrange,asdescribedinthetables,asquicklyastolerated(table2andtable3).Asanexample,risperidonecanbestartedat1to2mg/dayandtitratedtoatherapeuticdose(typically2to6mg/day).Ifasatisfactoryclinicalresponseisnotseenwithinsevendays,thedosecanbeincreasedin0.5to1mg/dayincrementstoamaximumof8mg/day.Ifthereisnoimprovementinpsychoticsymptomsaftertwoweeksofatherapeuticdose,adifferentantipsychoticshouldbeconsidered.Therecommendeddurationofantipsychotictherapyvariesaccordingto

  • 21/7/2015 Clinicalmanifestations,differentialdiagnosis,andinitialmanagementofpsychosisinadults

    http://www.uptodate.com.scihub.club/contents/clinicalmanifestationsdifferentialdiagnosisandinitialmanagementofpsychosisinadults?topicKey=P 7/16

    theunderlyingetiology:inchronicschizophrenia,antipsychoticsshouldbeofferedindefinitelytoreducerelapserisk[19]withtimelimitedpsychoses(suchasdelirium),antipsychotictherapycanbecontinuedfortwoweeksaftertheresolutionofsymptomsandthentaperedoffgradually.Theselectionamongantipsychoticdrugsandtheirdosingaredescribedindetailseparately.(See"Firstgenerationantipsychoticmedications:Pharmacology,administration,andcomparativesideeffects"and"Secondgenerationantipsychoticmedications:Pharmacology,administration,andcomparativesideeffects"and"Pharmacotherapyforschizophrenia:Acuteandmaintenancephasetreatment",sectionon'Acutephase'.)

    ConsultationorreferraltoapsychiatristAnypatientwithaninitialonsetofpsychosisshouldbeevaluatedbyapsychiatrist,whetherintheformofanurgentoutpatientpsychiatricconsultationorinanemergencyroomoraninpatientconsultationbyahospitalpsychiatrist.Presentingpatientsengagedinlongitudinaltreatmentforapsychoticdisorder(orotherdisorder/illnesswithpsychosis)shouldbeevaluatedifheorsheis:

    VoluntaryversusinvoluntarytreatmentPatientsatriskofharmtothemselvesorothersmayneedtobehospitalizedtoensuresafety.Evaluationandtreatmentforpsychosisshouldbevoluntarywheneverpossible,butthenatureoftheillnessmayleadpatientstofearoravoidtreatment.Inmoststates,dangerousnesstoselforothers,ortheinabilitytoprovideforone'sbasicneedsoffood,clothing,andshelter,issufficientcauseforinvoluntarytreatment.Thelegalmechanismforinitiatingthisdifferssignificantlybylegaljurisdiction.Clinicians,especiallythoseinemergencysettings,shouldbecomefamiliarwithinvoluntarytreatmentprocedureswithintheirlegaljurisdictions.Thelocalcommunitymentalhealthagencyorthenearestpsychiatricemergencyserviceshouldbeabletoassistwithinformation,legalforms,andotheraidinarranginginvoluntarycare.

    INFORMATIONFORPATIENTSUpToDateofferstwotypesofpatienteducationmaterials,TheBasicsandBeyondtheBasics.TheBasicspatienteducationpiecesarewritteninplainlanguage,atthe5thto6thgradereadinglevel,andtheyanswerthefourorfivekeyquestionsapatientmighthaveaboutagivencondition.Thesearticlesarebestforpatientswhowantageneraloverviewandwhoprefershort,easytoreadmaterials.BeyondtheBasicspatienteducationpiecesarelonger,moresophisticated,andmoredetailed.Thesearticlesarewrittenatthe10thto12thgradereadinglevelandarebestforpatientswhowantindepthinformationandarecomfortablewithsomemedicaljargon.

    Herearethepatienteducationarticlesthatarerelevanttothistopic.Weencourageyoutoprintoremailthesetopicstoyourpatients.(Youcanalsolocatepatienteducationarticlesonavarietyofsubjectsbysearchingonpatientinfoandthekeyword(s)ofinterest.)

    SUMMARYANDRECOMMENDATIONS

    ExperiencingamarkedincreaseinsymptomseverityDisplayingagitatedoraggressivebehaviorApossibledangertothemselvesorothersUnabletoprovidefortheirbasicneeds

    Basicstopics(see"Schizophrenia:Epidemiologyandpathogenesis"and"Patientinformation:Tardivedyskinesia(TheBasics)"and"Patientinformation:Bipolardisorder(TheBasics)")

    BeyondtheBasicstopics(see"Patientinformation:Bipolardisorder(manicdepression)(BeyondtheBasics)")

    Psychosisisaconditionofthemindbroadlydefinedasalossofcontactwithreality,whichoftenpresentswithdelusions,hallucinations,thoughtdisorganization,orunusualbehaviors.(See'Clinicalmanifestations'above.)

    Patientswithpsychosisareatelevatedriskforagitatedandaggressivebehaviors,andsafetyprecautionsshouldbeemployed.(See'Agitation/aggression'aboveand'Mentalstatusexamination'above.)

    Psychoticsymptomscanpresentinavarietyofpsychiatricandmedicalillnessesclinicalfeaturesarenotpathognomonicforparticulardiagnoses.(See'Psychosesassociatedwithmedicalorneurological

  • 21/7/2015 Clinicalmanifestations,differentialdiagnosis,andinitialmanagementofpsychosisinadults

    http://www.uptodate.com.scihub.club/contents/clinicalmanifestationsdifferentialdiagnosisandinitialmanagementofpsychosisinadults?topicKey=P 8/16

    UseofUpToDateissubjecttotheSubscriptionandLicenseAgreement.

    REFERENCES

    1. vanOsJ,HanssenM,BijlRV,VolleberghW.Prevalenceofpsychoticdisorderandcommunitylevelofpsychoticsymptoms:anurbanruralcomparison.ArchGenPsychiatry200158:663.

    2. PerlJ,SuvisaariJ,SaarniSI,etal.LifetimeprevalenceofpsychoticandbipolarIdisordersinageneralpopulation.ArchGenPsychiatry200764:19.

    3. SadockBJ,SadockVA,KaplanHI.KaplanandSadock'sComprehensiveTextbookofPsychiatry,LippincottWilliams&Wilkins,2009.Vol1.

    4. SheitmanBB,LeeH,StrousR,LiebermanJA.Theevaluationandtreatmentoffirstepisodepsychosis.SchizophrBull199723:653.

    5. AmericanPsychiatricAssociation.DiagnosticandStatisticalManualofMentalDisorders,FifthEdition(DSM5),AmericanPsychiatricAssociation,Arlington,VA2013.

    6. FiorentiniA,VolonteriLS,DragognaF,etal.Substanceinducedpsychoses:acriticalreviewoftheliterature.CurrDrugAbuseRev20114:228.

    7. WebsterR,HolroydS.Prevalenceofpsychoticsymptomsindelirium.Psychosomatics200041:519.8. LeentjensAF,RundellJ,RummansT,etal.Delirium:Anevidencebasedmedicine(EBM)monograph

    forpsychosomaticmedicinepractice,comissionedbytheAcademyofPsychosomaticMedicine(APM)andtheEuropeanAssociationofConsultationLiaisonPsychiatryandPsychosomatics(EACLPP).JPsychosomRes201273:149.

    9. JellingerKA.Cerebralcorrelatesofpsychoticsyndromesinneurodegenerativediseases.JCellMolMed201216:995.

    10. FreudenreichO,SchulzSC,GoffDC.Initialmedicalworkupoffirstepisodepsychosis:aconceptualreview.EarlyIntervPsychiatry20093:10.

    11. FirstMB.DSM5HandbookofDifferentialDiagnosis,AmericanPsychiatricPublishing,Arlington,VA2013.

    conditions'above.)

    Itisimportanttoperformathoroughhistory,physicalexamination,mentalstatusexamination,andworkupinordertoruleouttreatableunderlyingcausesofpsychosisandguideappropriatetherapy(See'Diagnosticevaluation'above.)

    Patientswithpsychosisshouldbeevaluatedforagitation,riskofharmtothemselvesorothers,andtheirabilitytotakecareofthemselves.Patientsatriskofharmmayneedtobehospitalized.Severelyagitatedpatientswithpsychosismayimmediatesedationorotherrestraint.(See'Initialmanagement'aboveand"Assessmentandemergencymanagementoftheacutelyagitatedorviolentadult".)

    Werecommendsymptomatictreatmentofpsychosiswithanantipsychoticmedication,evenifthespecificpsychiatricdisorderormedicalconditionunderlyingthepsychosishasnotyetbeenestablished(Grade1B).Asantipsychoticdrugsarelargelysimilarinefficacy,selectionamongthemistypicallymadeonthebasisofpatientpresentationandthemedicationssideeffectprofile,cost,andformulationsavailable(table2andtable3).(See'Initialmanagement'above.)

    Asanexample,risperidonecanbestartedat1to2mg/dayandtitratedtoatherapeuticdose(typically2to6mg/day).Ifasatisfactoryclinicalresponseisnotachievedaftersevendays,thedosecanbeincreasedinincrementsof0.5to1mg/daytoamaximumof8mg/day.(See'Initialmanagement'above.)

    Antipsychotictreatmentistypicallyadministeredincombinationwithtreatmentoftheunderlyingcondition.Thisappliestomedicalconditionscausingpsychosisaswellasamooddisorderexacerbationorsubstanceusedisorder.(See"Unipolarmajordepressionwithpsychoticfeatures:Acutetreatment"and"Bipolardisorderinadults:Pharmacotherapyforacutemaniaandhypomania"and"Pharmacotherapyforschizophrenia:Acuteandmaintenancephasetreatment"and"Treatmentofcooccurringschizophreniaandsubstanceusedisorder"and"Psychosocialinterventionsforschizophrenia"and"Briefpsychoticdisorder".)

  • 21/7/2015 Clinicalmanifestations,differentialdiagnosis,andinitialmanagementofpsychosisinadults

    http://www.uptodate.com.scihub.club/contents/clinicalmanifestationsdifferentialdiagnosisandinitialmanagementofpsychosisinadults?topicKey=P 9/16

    12. YildizA,VietaE,LeuchtS,BaldessariniRJ.Efficacyofantimanictreatments:metaanalysisofrandomized,controlledtrials.Neuropsychopharmacology201136:375.

    13. WijkstraJ,LijmerJ,BurgerH,etal.Pharmacologicaltreatmentforpsychoticdepression.CochraneDatabaseSystRev201311:CD004044.

    14. WangHR,WooYS,BahkWM.Atypicalantipsychoticsinthetreatmentofdelirium.PsychiatryClinNeurosci201367:323.

    15. FrielingH,HillemacherT,ZiegenbeinM,etal.TreatingdopamimeticpsychosisinParkinson'sdisease:structuredreviewandmetaanalysis.EurNeuropsychopharmacol200717:165.

    16. KatzI,deDeynPP,MintzerJ,etal.TheefficacyandsafetyofrisperidoneinthetreatmentofpsychosisofAlzheimer'sdiseaseandmixeddementia:ametaanalysisof4placebocontrolledclinicaltrials.IntJGeriatrPsychiatry200722:475.

    17. CaasF.Managementofagitationintheacutepsychoticpatientefficacywithoutexcessivesedation.EurNeuropsychopharmacol200717Suppl2:S108.

    18. RingbckWeitoftG,BerglundM,LindstrmEA,etal.Mortality,attemptedsuicide,rehospitalisationandprescriptionrefillforclozapineandotherantipsychoticsinSwedenaregisterbasedstudy.PharmacoepidemiolDrugSaf201423:290.

    19. BuchananRW,KreyenbuhlJ,KellyDL,etal.The2009schizophreniaPORTpsychopharmacologicaltreatmentrecommendationsandsummarystatements.SchizophrBull201036:71.

    Topic17193Version5.0

  • 21/7/2015 Clinicalmanifestations,differentialdiagnosis,andinitialmanagementofpsychosisinadults

    http://www.uptodate.com.scihub.club/contents/clinicalmanifestationsdifferentialdiagnosisandinitialmanagementofpsychosisinadults?topicKey= 10/16

    GRAPHICS

    Substancesandmedicationswithcapacitytoinducepsychosis

    Substanceormedication

    Examples

    Alcoholandsedatives/hypnotics

    Alcohol(intoxicationorwithdrawal),barbituratesandbenzodiazepines(particularlywithdrawal)

    Anabolicsteroids Testosterone,methyltestosterone

    Analgesics Meperidine,pentazocine,indomethacin

    Anticholinergics Atropine,scopolamine

    Antidepressants Bupropion,othersiftriggeringamanicswitch

    Antiepileptics Zonisamide,otheranticonvulsantsathighdoses

    Antimalarial Mefloquine,chloroquine

    Antiparkinsonian Levodopa,selegiline,amantadine,pramipexole,bromocriptine

    Antivirals Abacavir,efavirenz,nevirapine,acyclovir

    Cannabinoids Marijuana,syntheticcannabinoids(ie,"spice"),dronabinol

    Cardiovascular Digoxin,disopyramide,propafenone,quinidine

    Corticosteroids Prednisone,dexamethasone,etc

    Hallucinogens LSD,PCP(phencyclidine),ketamine,psilocybincontainingmushrooms,mescaline,synthetic"designerdrugs"(eg,2CB,"NBomb"[25INBOMe]),salviadivinorum

    Inhalants Toluene,butane,gasoline

    Interferons Interferonalfa2a/2b

    Overthecounter(OTC) Dextromethorphan(DXM),diphenhydramine,somedecongestants

    Stimulants Cocaine,amphetamine/methamphetamine,methylphenidate,certaindietpills,"bathsalts"(MDPV,mephedrone),MDMA/ecstasy

    Toxins Carbonmonoxide,organophosphates,heavymetals(eg,arsenic,manganese,mercury,thallium)

    Graphic96392Version1.0

    SciHub

  • 21/7/2015 Clinicalmanifestations,differentialdiagnosis,andinitialmanagementofpsychosisinadults

    http://www.uptodate.com.scihub.club/contents/clinicalmanifestationsdifferentialdiagnosisandinitialmanagementofpsychosisinadults?topicKey= 11/16

    Selectedadverseeffectsofantipsychoticmedicationsforschizophrenia

    Weight

    gain/diabetesmellitus

    Hypercholesterolemia EPS/TD

    Prolactinelevation Sedation

    Firstgenerationagents

    Chlorpromazine +++ +++ + ++ +++

    Fluphenazine + + +++ +++ +

    Haloperidol + + +++ +++ ++

    Loxapine ++ ND ++ ++ ++

    Perphenazine ++ ND ++ ++ ++

    Pimozide + ND +++ ++ +

    Thioridazine* ++ ND + +++ +++

    Thiothixene ++ ND +++ ++ +

    Trifluoperazine ++ ND +++ ++ +

    Secondgenerationagents

    Aripiprazole + ++ +

    Asenapine ++ ++ ++ ++

    Clozapine ++++ ++++ +++

    Iloperidone ++ ++ +

    Lurasidone + ++ ++

    Olanzapine ++++ ++++ + + ++

    Paliperidone +++ + ++ +++ +

    Quetiapine +++ +++ ++

    Risperidone +++ + +++ +++ +

    Ziprasidone + + +

    Adverseeffectsmaybedosedependent.

    EPS:extrapyramidalsymptomsTD:tardivedyskinesiaND:nodata.*Thioridazineisalsoassociatedwithdosedependentretinitispigmentosa.Refertotext.Clozapinealsocausesgranulocytopeniaoragranulocytosisinapproximately1percentofpatientsrequiringregularbloodcellcountmonitoring.Clozapinehasbeenassociatedwithexcessriskofmyocarditisandvenousthromboemboliceventsincludingfatalpulmonaryembolism.TheseissuesareaddressedintheUpToDatetopicreviewofguidelinesforprescribingclozapinesectiononadverseeffects.

    Adaptedwithspecialpermissionfrom:1. TreatmentGuidelinesfromTheMedicalLetter,June2013Vol.11(130):53.

    www.medicalletter.org.Additionaldatafrom:

    RummelKlugeC,etal.Headtoheadcomparisonsofmetabolicsideeffectsofsecondgenerationantipsychoticsinthetreatmentofschizophrenia:asystematicreviewandmetaanalysisSchizophrRes,November,2010123:225.

    [1]

  • 21/7/2015 Clinicalmanifestations,differentialdiagnosis,andinitialmanagementofpsychosisinadults

    http://www.uptodate.com.scihub.club/contents/clinicalmanifestationsdifferentialdiagnosisandinitialmanagementofpsychosisinadults?topicKey= 12/16

    DurnCE,AzermaiM,VanderSticheleRH.Systematicreviewofanticholinergicriskscalesinolderadults.EurJClinPharmacol201369:1485.

    Graphic82533Version18.0

  • 21/7/2015 Clinicalmanifestations,differentialdiagnosis,andinitialmanagementofpsychosisinadults

    http://www.uptodate.com.scihub.club/contents/clinicalmanifestationsdifferentialdiagnosisandinitialmanagementofpsychosisinadults?topicKey= 13/16

    Pharmacologyofantipsychotics:Dosing(adult),formulations,kineticsandpotentialfordruginteractions

    Agent

    Usualoraldoserange

    (mg/day)

    Initialoraldose(mg/day)

    Usualmaximumoraldose(mg/day)*

    Formulations

    Halflifeafteroral

    administration(hours)

    Firstgenerationantipsychotics(FGAs)

    Chlorpromazine 400to600 25to200 800 Tab,IM 30

    Fluphenazine 2to15 2to10 12 Tab,IM,LAI,oralsolution

    33

    Haloperidol 2to20 2to10 30 Tab,IM,LAI,oralsolution

    20

    Loxapine 2080 20 100 CapsuleoralinhalationforuseinhealthcaresettingsasalternativetoIMinjection

    OralsolutionandIMinjectionavailableincountriesotherthanUnitedStates

    12

    Perphenazine 12to24 8to16 24 Tab 912

    Pimozide 8to10 1to2 10

    4(CYP2D6poormetabolizer)

    Tab 55

    Thiothixene(tiotixene)

    10to20 5to10 30 Capsule 33

    Thioridazine 200to600 150 600 Tab 2125

  • 21/7/2015 Clinicalmanifestations,differentialdiagnosis,andinitialmanagementofpsychosisinadults

    http://www.uptodate.com.scihub.club/contents/clinicalmanifestationsdifferentialdiagnosisandinitialmanagementofpsychosisinadults?topicKey= 14/16

    Trifluoperazine 15to20 4to10 40 Tab 22

    Secondgenerationantipsychotics(SGAs)

    Aripiprazole 10to15 10to15 30 Tab,ODT,IM,LAI,oralsolution

    7594

    Asenapine 10to20 10 20 Sublingualtab 24

    Clozapine 150to600 2550 900 Tab,ODT,oralsuspension

    12

    Iloperidone 12to24 2 24

    12(CYP2D6poormetabolizerorreceiving2D6inhibitorcotreatment)

    Tab 1826

    Lurasidone 40to80 40

    20(renalorhepaticinsufficiency)

    160

    80(moderateorsevererenalinsufficiency,moderatehepaticinsufficiency)

    40(severehepaticinsufficiency)

    Tab 2937(steadystate)

    Olanzapine 10to20 5to10 30 Tab,ODT,IM,LAI 3038

    Paliperidone 6to12 6 12 ERtab,LAI 23

    Quetiapine 150to750(immediaterelease)

    400to800(extended

    50 750(immediaterelease)

    800(extendedrelease)

    Tab,ERtab 612

  • 21/7/2015 Clinicalmanifestations,differentialdiagnosis,andinitialmanagementofpsychosisinadults

    http://www.uptodate.com.scihub.club/contents/clinicalmanifestationsdifferentialdiagnosisandinitialmanagementofpsychosisinadults?topicKey= 15/16

    release)

    Risperidone 2to6 1to2 8 Tab,ODT,LAI,oralsolution

    20

    Ziprasidone 40to160 40to80 200 Capsule,IM 7oral

    25IM

    Dosesshownaretotaldailydose,oraladministration,formaintenancetreatmentofschizophreniainotherwisehealthyadults.Foradditionalinformation,refertoLexicompindividualdrugmonographsincludedwithUpToDate.

    ODT:orallydissolvingtabletTab:tabletERtab:extendedreleasetabletIM:shortactingintramuscularinjectionLAI:longactinginjectable(eg,depot)CYP:cytochromeP450Pgp:membranePglycoproteintransportersUGTglucuronidation:uridine5'diphosphateglucuronyltransferases.*Usualmaximumtotaloraldailydoseformaintenancetreatmentofschizophreniainadultpatientswithoutsignificantcomorbidity.Dosesshownmaynotbethemaximumdoseusedinsomeclinicaltrialsorinexceptionalpatients.Onlypotenttomoderateinhibitoreffectsarelistedinthistable.Foradditionalinformationincludingmoderatetoweakinhibitororinducereffects,andtodeterminespecificdruginteractions,refertoindividualdrugmonographssectionondruginteractionsandtheLexiInteractprogramincludedwithUpToDate.SmokingmaydecreasebloodconcentrationsofantipsychoticsprimarilymetabolizedbyCYP1A2.

    Preparedwithdatafrom:1. LexicompOnline.Copyright19782015Lexicomp,Inc.AllRightsReserved.2. WynnGH,etal(eds)ClinicalManualofDrugInteractionPrinciplesforMedicalPracticeAPA

    publishing,WashingtonDC.Copyright2009.

    Graphic60624Version21.0

  • 21/7/2015 Clinicalmanifestations,differentialdiagnosis,andinitialmanagementofpsychosisinadults

    http://www.uptodate.com.scihub.club/contents/clinicalmanifestationsdifferentialdiagnosisandinitialmanagementofpsychosisinadults?topicKey= 16/16

    Disclosures:StephenMarder,MDGrant/Research/ClinicalTrialSupport:Sunovion[Psychosis(Lurasidone)].Consultant/AdvisoryBoards:Otsuka[Psychosis(Aripiprazole,brexpiprazole)]Lundbeck[Psychosis(Aripiprazole,brexpiprazole]Pfizer[Psychosis(Ziprasidone)].MichaelDavis,MD,PhDNothingtodisclose.MurrayBStein,MD,MPHGrant/Research/ClinicalTrialSupport:Janssen[socialanxietydisorder].Consultant/AdvisoryBoards:Janssen[anxietyandtraumaticstress]Tonix[anxietyandtraumaticstress]Pfizer[anxietyandtraumaticstress].RichardHermann,MDNothingtodisclose.Contributordisclosuresarereviewedforconflictsofinterestbytheeditorialgroup.Whenfound,theseareaddressedbyvettingthroughamultilevelreviewprocess,andthroughrequirementsforreferencestobeprovidedtosupportthecontent.AppropriatelyreferencedcontentisrequiredofallauthorsandmustconformtoUpToDatestandardsofevidence.Conflictofinterestpolicy

    Disclosures

Recommended